Ozempic and Mounjaro Set to Disrupt India’s Food and Alcohol Markets

Patent expiry, generics and global consumption shifts could push Ozempic and Mounjaro into India’s mass market, reshaping obesity care and consumer spending Ozempic India patent expiry, Mounjaro India launch, GLP-1…

WHO’s Obesity Guidelines: Benefits, Risks, and Long-Term Use of GLP-1 Drugs

The World Health Organization now recognizes obesity as a chronic disease and recommends GLP-1 weight loss drugs such as Ozempic and Mounjaro as part of long-term treatment. Until now, the…